(03) 8373 4646

Erythematotelangiectatic Rosacea: Persistent Redness, Flushing & Broken Capillaries

Rosacea redness treatment in Melbourne (Ivanhoe + Diamond Creek)

Doctor-led care for flushing, persistent facial redness, and visible capillaries — with supportive dermal therapy to calm reactivity and improve long-term results.

If your rosacea is mainly redness and flushing (with or without visible “broken capillaries”), you likely have erythematotelangiectatic rosacea (ETR). This subtype responds best when we treat both:

  • the vascular driver (dilated, reactive facial blood vessels), and
  • the skin barrier (sensitivity, burning, product intolerance). (1–4)

Best results usually come from a combined pathway:
20 minutes with Dr Chris (diagnosis + medical/laser plan) followed by 40 minutes with a dermal therapist (barrier repair routine + trigger strategy + LED/skin support). This combination is often what turns rosacea from “constant flare-ups” into long stable periods.

[Book appointment] (Rosacea Consultation + Dermal Therapist Review)
[Book] (Rosacea Laser / Redness Treatment)

Key takeaways

  • ETR rosacea is mainly vascular: flushing can evolve into persistent background redness and visible capillaries over time. (1–4)
  • Skincare and trigger strategies help, but persistent redness and vessels often improve most with vascular laser because it targets the vessels themselves. (1–4, 11–13)
  • Brimonidine tartrate gel 0.33% (Mirvaso) can temporarily reduce redness by vasoconstriction, but it is best positioned as special-occasion use because some people experience worsening or rebound redness. (5–7, 9–10)
  • The highest-yield starting point is usually doctor + dermal therapist together: medical/laser strategy plus a barrier-first routine that makes treatments easier to tolerate and helps results last longer. (1–4)

Jump links

  • What ETR rosacea looks like
  • Why redness becomes persistent
  • Step 1: Stabilise the skin barrier (with dermal therapist support)
  • Step 2: Identify your triggers (and keep living normally)
  • Brimonidine gel (Mirvaso): how it works and why we limit use
  • Step 3: Vascular laser: how it helps ETR rosacea
  • What results to expect
  • What to avoid (common flare loops)
  • Medicare notes (selected cases)
  • When to book a review
  • FAQs
  • Book

What ETR rosacea looks like

ETR rosacea typically includes:

  • flushing triggered by heat, stress, alcohol, spicy foods, exercise, sun or wind
  • persistent background redness that doesn’t fully settle between flares
  • visible capillaries (telangiectasia) on cheeks, nose, chin or around the nose
  • skin that feels sensitive (stinging, burning, reacting to products) (1–4)

If your main issue is inflamed bumps/pustules, go to Rosacea Bumps and Pimples: Papulopustular Rosacea Treatment Plan (Melbourne) (Papulopustular rosacea plan). (1–4)

Why redness becomes persistent

Early rosacea is often “on/off” flushing. Over time, repeated vessel dilation and inflammation can contribute to:

  • a larger network of permanently dilated superficial vessels
  • more visible capillaries
  • more persistent baseline redness (1–4)

That’s why moisturisers can help comfort but often don’t shift the visible vascular redness by themselves.

Step 1: Stabilise the skin barrier (first 2 weeks)

This is the step most patients underestimate — and it’s where a dermal therapist appointment makes a real difference.

Why barrier stabilisation matters

When the barrier is inflamed and leaky, you get:

  • stinging and burning
  • “everything makes me flare” product intolerance
  • worse flushing from minor triggers
  • poor tolerance of prescribed treatments (1–4)

What a dermal therapist adds (and why it improves outcomes)

A dermal therapist appointment can help you:

  • build a simple, tolerable routine (cleanser, moisturiser, sunscreen)
  • identify which ingredients to avoid (fragrance, harsh actives, alcohol-heavy products)
  • choose the right format for your skin (cream vs gel vs lotion)
  • plan supportive treatments such as calming LED in between flare periods
  • reduce day-to-day reactivity so vascular laser and medical therapy are better tolerated and longer lasting

Your best “start here” booking

For most ETR rosacea patients, the highest-yield starting point is:
20 minutes with Dr Chris + 40 minutes with a dermal therapist.
We confirm the diagnosis, decide whether redness is vascular-dominant, and then lock in a barrier plan that makes everything easier.

[Book appointment] (Rosacea Consultation + Dermal Therapist Review)

Step 2: Identify your triggers (and keep living normally)

Triggers vary, but patterns are usually predictable. Rather than trying to avoid everything, aim to identify your top two triggers and manage them intelligently.

Common high-yield triggers include:

  • heat/hot showers
  • sun exposure
  • alcohol (especially red wine)
  • spicy foods / hot drinks
  • stress and poor sleep
  • exercise overheating (cooling strategies help you keep training) (1–4)

How the dermal therapist helps with triggers

A dermal therapist helps you translate “triggers” into practical routines:

  • sunscreen choice that you’ll actually wear daily
  • barrier support to reduce wind/heat reactivity
  • post-exercise cooling and skincare steps
  • product simplification to prevent irritant flares

If you want the fast lane to stability, book the combined pathway.

[Book appointment] (Rosacea Consultation + Dermal Therapist Review)

Brimonidine tartrate gel 0.33% (Mirvaso)

This is a “redness-only” prescription gel sometimes used for ETR rosacea.

How it works

Brimonidine is an alpha-2 adrenergic agonist. It temporarily narrows superficial vessels (vasoconstriction), reducing visible redness for several hours. (5–7, 9–10)

When it’s useful

  • short-term redness reduction for an event, presentation, or photos (5–7)

Why we position it as special-occasion use

Some people experience worsening erythema or rebound redness as it wears off, or increased flushing during treatment. (5–7, 10)
Practical approach:

  • do a “trial run” on a normal day first
  • use the smallest effective amount
  • avoid applying to irritated skin
  • stop if it worsens redness and switch strategies (5–7)

Brimonidine can reduce redness temporarily, but it does not remove visible capillaries — laser is more direct for that. (11–13)

Step 3: Vascular laser (Fotona SP Dynamis Pro Nd:YAG 1064 nm)

When persistent background redness and visible thread veins (telangiectasia) are the dominant problem, vascular laser is often the most effective treatment because it targets the blood-vessel network that creates the red appearance. Medications can help inflammation, flushing and bumps, but they often have limited impact on fixed background erythema and established telangiectasia, which is where laser and light-based devices come in. (11–13, 23)

Why we choose 1064 nm Nd:YAG for ETR

Rosacea vessels are not always purely superficial. In many people, part of the vascular “load” sits deeper in the dermis (particularly around the nose and central cheeks). The 1064 nm Nd:YAG wavelength penetrates more deeply than many other vascular wavelengths, which makes it a strong option when deeper or thicker vessels contribute to persistent redness. (11–13)

That depth matters clinically. In rosacea-associated nasal telangiectasia, both pulsed dye laser (PDL) and long-pulsed Nd:YAG can work well overall — but thicker, more dilated vessels responded better to Nd:YAG, while mild erythema with finer telangiectasia tended to respond better to PDL. (21)
 Translation: if your rosacea is vessel-dominant (especially thicker vessels and “red zones” around the nose), Nd:YAG is often a particularly good fit.

What the Fotona platform adds (why the platform matters)

The advantage isn’t the brand name alone — it’s having a medical-grade Nd:YAG system that allows precise control of pulse structure, spot size, and energy, so treatment can be tailored to the vessel pattern we see on your face while prioritising skin safety and comfort.

The 1064 nm wavelength also has relatively low melanin absorption compared with shorter vascular wavelengths, which is one reason Nd:YAG is widely used when pigmentation risk is a concern. (11–13)

Simple explanation: what’s happening under the skin

  • The laser energy is absorbed by blood within dilated vessels.
  • The vessel is heated enough to seal/collapse, reducing its visibility.
  • Over the following weeks, your body clears the treated vessel and the redness progressively settles.

Evidence: how effective is repeated Nd:YAG for rosacea redness?

We focus on outcomes that matter to patients: visible redness, visible vessels, and downtime.

1) Larger clinical study shows strongest benefit in ETR-type disease
 In a prospective study of 66 patients treated with long-pulsed 1064 nm Nd:YAG at 3–4 week intervals, the ETR group improved more than papulopustular rosacea, and the authors reported good-to-excellent outcomes in up to ~50% of patients (with common patient-reported improvement). Significant adverse effects were uncommon (two hypopigmented atrophic scars reported). (12)

2) Split-face ETR study: high “excellent response” rates and minimal bruising on Nd:YAG side
 In a split-face study of ETR, an excellent response was reported more frequently on the Nd:YAG side than on the PDL side, and purpura (bruising) occurred on the PDL side but not on the Nd:YAG side. The study also found improvements in patient-reported skin sensitivity. (20)

3) Meta-analysis context: no single “winner” overall — which is exactly why tailoring matters
 When researchers pool comparative trials, overall outcomes and patient satisfaction are often similar between PDL and Nd:YAG, meaning “best” depends on your subtype (diffuse erythema vs deeper vessels), your skin type, and your downtime tolerance. (11)

What Nd:YAG is best for in ETR rosacea

  • Visible thread veins (telangiectasia), especially thicker/deeper vessels (20–21)
  • Persistent background redness that doesn’t fully settle with skincare/medication (11–13, 23)
  • Long-standing “red zones” on cheeks and around the nose (11–13)

Laser won’t replace barrier care or trigger strategy — but it can materially reduce the vascular load that keeps your face looking red day-to-day. (11–13)

[Book] (Rosacea Laser / Redness Treatment)

What results to expect

Most patients notice:

  • reduced visible capillaries
  • reduced background redness
  • a calmer, more even complexion over time (11–13)

The best results usually build after a series of sessions, as clearance accumulates over weeks. (11–13)

What to avoid (common flare loops)

  • harsh exfoliation, scrubs, frequent acids (especially when reactive) (1–4)
  • fragrance, menthol, alcohol-heavy toners, “tingly” products (1–4)
  • repeated topical steroid use on the face (can worsen rosacea-like eruptions and trigger peri-orificial dermatitis) (4, 18–19)
  • frequent overheating without cooling strategies (exercise is still encouraged — the trick is heat control) (1–4)

Medicare notes (selected cases)

Some vascular laser for certain vascular abnormalities of the head or neck may be eligible for a Medicare rebate under MBS item 14100 when strict criteria are met (visibility + photographic documentation + session limits). (14–17)
This is not automatically applicable to rosacea. Eligibility is assessed case-by-case during consultation. (14–17)

When to book a review

Book a rosacea consultation if:

Best starting point:
[Book appointment] (Rosacea Consultation + Dermal Therapist Review)

FAQs

Is ETR rosacea the same as “broken capillaries”?
Broken capillaries are common in ETR, but ETR also includes flushing and persistent redness even when vessels aren’t obvious. (1–4)

Does brimonidine (Mirvaso) fix rosacea long-term?
It’s a temporary vasoconstrictor. It can help for short-term redness reduction, but it doesn’t remove vessels and can cause rebound redness in some people — so we usually reserve it for special occasions rather than daily long-term use. (5–7, 10)

Does laser help flushing?
Laser is most reliable for persistent redness and visible vessels. Some people find flushing is less intense once vascular load is reduced, but triggers still matter and need their own plan. (1–4, 11–13)

Why book a dermal therapist appointment as well?
Because barrier instability and product intolerance are often the hidden reason people don’t progress. Dermal therapy helps you build a routine you can tolerate, reduce day-to-day reactivity, and improve comfort and durability of results (including after laser). (1–4)

Book

If your main rosacea issue is persistent redness, flushing, or broken capillaries, we can confirm the pattern (and any overlap) and build a staged plan — including vascular laser where appropriate, and dermal therapy support to calm reactivity and help results last.

[Book appointment] (Rosacea Consultation + Dermal Therapist Review)
[Book] (Rosacea Laser / Redness Treatment)
Clinics: Ivanhoe + Diamond Creek

References

1.DermNet NZ. Rosacea.
Link: https://dermnetnz.org/topics/rosacea

2.Australasian College of Dermatologists. Rosacea.
Link: https://www.dermcoll.edu.au/atoz/rosacea/

3.RACGP (AFP). Rosacea.
Link: https://www.racgp.org.au/afp/2017/may/rosacea

4.Australian Prescriber. An update on the treatment of rosacea.
Link: https://australianprescriber.tg.org.au/articles/an-update-on-the-treatment-of-rosacea.html

5.NPS MedicineWise. Mirvaso gel (brimonidine) — consumer information.
Link: https://www.nps.org.au/medicine-finder/mirvaso-gel

6.NPS MedicineWise. Mirvaso consumer medicine information (PDF).
Link: https://www.nps.org.au/assets/medicines/173b62dc-e454-4815-890c-a53300ff959c.pdf

7.U.S. FDA label: Mirvaso (brimonidine) topical gel 0.33%.
Link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204708s005lbl.pdf

8.BMJ Drug and Therapeutics Bulletin. Brimonidine for erythema caused by rosacea.
Link: https://dtb.bmj.com/content/52/12/138

9.Holmes AD, et al. Dermatological adverse events associated with topical brimonidine gel 0.33% in subjects with erythema of rosacea: a retrospective review of clinical studies. J Am Acad Dermatol. 2015.
PubMed: https://pubmed.ncbi.nlm.nih.gov/26345379/

10.Drug safety communication: brimonidine gel (Mirvaso) risk of exacerbation/rebound (regulator bulletin).
Link: https://www.drugoffice.gov.hk/eps/upload/eps_news/26962/GB/1/Brimonidine%20gel%20%28Mirvaso%29%20-%20risk%20of%20exacerbation%20of%20rosacea.pdf

11.Li Y, et al. Efficacy comparison of pulsed dye laser vs microsecond 1064-nm Nd:YAG laser for the treatment of rosacea: meta-analysis. Front Med. 2022.
PubMed/PMC: https://pubmed.ncbi.nlm.nih.gov/35118179/

12.Say EM, Okan G, Gökdemir G. Treatment outcomes of long-pulsed Nd:YAG laser for two different subtypes of rosacea. J Clin Aesthet Dermatol. 2015.
PubMed/PMC: https://pubmed.ncbi.nlm.nih.gov/26430486/

13.Yepuri V, et al. Light-based devices for the treatment of facial erythema and telangiectasia. Dermatol Ther (Heidelb). 2021.
PubMed/PMC: https://pubmed.ncbi.nlm.nih.gov/34562267/

14.MBS Online. Item 14100 — laser photocoagulation for vascular abnormalities of head/neck.
Link: https://www9.health.gov.au/mbs/fullDisplay.cfm?q=14100&qt=item&type=item

15.Services Australia. MBS billing notes (vascular laser items).
Link: https://www.servicesaustralia.gov.au/mbs-billing-for-skin-lesion-treatment-and-biopsy-items?context=20

16.PrivateHealth.gov.au. MBS item 14100 summary.
Link: https://www.privatehealth.gov.au/dynamic/MBSItems/Skin/14100

17.MBS Online factsheet (dermatology changes; photographic evidence requirements).
Link: https://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Factsheet-DermatologyAllergy

18.DermNet NZ. Periorificial dermatitis.
Link: https://dermnetnz.org/topics/periorificial-dermatitis

19.Australasian College of Dermatologists. Perioral dermatitis.
Link: https://www.dermcoll.edu.au/atoz/perioral-dermatitis/

20.Salem SAM, et al. Neodymium:yttrium-aluminum-garnet laser versus pulsed dye laser in erythematotelangiectatic rosacea: split-face comparative study. J Cosmet Dermatol. 2013.
PubMed: https://pubmed.ncbi.nlm.nih.gov/23992160/

21.Kwon HH, et al. Comparison of long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia. Dermatol Surg. 2018.
PubMed: https://pubmed.ncbi.nlm.nih.gov/29388843/

22.Park S, et al. A randomized split-face comparative study of long-pulsed Nd:YAG (and comparator vascular laser) for rosacea erythema index reduction. [Journal] 2022.
PubMed: https://pubmed.ncbi.nlm.nih.gov/36183378/

23.Micali G, et al. Improving treatment of erythematotelangiectatic rosacea by discriminating symptoms: background erythema, flushing, telangiectasia. Clin Cosmet Investig Dermatol. 2016.
PubMed/PMC: https://pubmed.ncbi.nlm.nih.gov/27110148/

24.Nguyen L, et al. Laser and energy-based devices for treating rosacea: systematic review and network meta-analysis. J Dtsch Dermatol Ges. Epub 2025; print 2026.
PubMed/PMC: https://pubmed.ncbi.nlm.nih.gov/41273013/